IRVINE, Calif., January, 8, 2026 – W. L. Gore & Associates, Inc. (Gore) a global materials science company dedicated to transforming industries and improving lives, announced this week that it has entered into a definitive agreement to acquire Conformal Medical, Inc., an innovative medical device company developing the investigational CLAAS® AcuFORM™ System, a next-generation left atrial appendage occlusion (LAAO) technology. A team from Knobbe Martens advised Conformal Medical on intellectual property aspects of the deal.
The investigational Conformal CLAAS AcuFORM System has the potential to transform LAAO into a same-day procedure, moving clinical practice away from general anesthesia and overnight hospitalizations. The investigational CLAAS AcuFORM System is currently in clinical testing and not available for commercial use.
LAAO is a one-time procedure for patients with non-valvular atrial fibrillation (AFib) that aims to reduce the risk of stroke-causing blood clots forming in the LAA and eliminate the need for long-term daily oral anticoagulant therapy.
The transaction is expected to close in early 2026, subject to regulatory approval. More information on the deal can be found here.
The Knobbe Martens team who advised on the deal includes Tom Cowan, Brian Flynn, Ian Gillies, and James Raleigh.
About Knobbe Martens
Knobbe Martens protects the ideas that drive innovation and propel our world forward. As a leading intellectual property and technology law firm, clients worldwide rely on us to safeguard their products, brands, and technologies through strategic counsel and high-impact litigation. With offices across the U.S., our lawyers and technology specialists collaborate to deliver tailored solutions for clients ranging from multinational corporations to start-ups and emerging companies at every stage. Discover more at www.knobbe.com.
Subscribe for News and Updates
